Member states of the World Trade Organization (WTO) recently agreed to a waiver of intellectual property (IP) protections for COVID-19 vaccines as part of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement. Included in this unnecessary and harmful decision, countries were given six months to decide whether to expand the waiver to COVID-19 treatments and diagnostics.
